Methods and systems for scoring extracellular matrix biomarkers in tumor samples
A biomarker and tumor technology, applied in the preparation of test samples, biochemical equipment and methods, sampling, etc., can solve the problems of complex evaluation, inconsistency, and inability to reproduce stained tissue samples
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0140] Example 1 describes testing of the scoring assay of the present disclosure.
[0141] During testing of the scoring method of the present disclosure, multiple samples from cell lines and xenografts (PC3, BxPC3 and DU145), normal human tissues as well as tumor tissue samples such as PDA, breast cancer, non-small cell lung cancer (NSCLC) and gastric cancer were used. tissue samples. Samples were stained on the VENTANA BenchMark automated slide staining system using TSG6-rabbit Fc fusion protein (TSG6-Fclb) as a biomarker-specific reagent and the VENTANA OptiView DAB IHC Detection Kit. Affinity histochemistry assay was used to select patients with pancreatic ductal adenocarcinoma (PDA) containing hyaluronan (HA) who could benefit from PEGPH20 adjuvant therapy using a cutoff between high and low HA 50% staining of tumor-associated ECM at any HA intensity above background.
[0142] Figure 4A Examples of samples scored using the methods of the present disclosure are shown....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com